Request Deal Involvement

Supernus Pharmaceuticals to acquire Sage Therapeutics for $795m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goldman Sachs

financial advisors

Goldman Sachs

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Joele Frank

pr advisors

Joele Frank

Moelis & Co

financial advisors

Moelis & Co

Saul Ewing Arnstein & Lehr

legal advisors

Saul Ewing Arnstein & Lehr

ICR Healthcare

pr advisors

ICR Healthcare

or

Principals

SAGE THERAPEUTICS

target

SAGE THERAPEUTICS

SUPERNUS PHARMACEUTICALS

bidder

SUPERNUS PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Supernus Pharmaceuticals to acquire Sage Therapeutics for $795m.